'Testosterone replacement is strictly
contraindicated for the treatment
of male infertility’ was the advanced view
from the ‘2013 European Association of
Urology (EAU) guidelines on male infertility’,
and this view brings extensive concern and
questions. Although sufficient numbers
of well-performed and controlled clinical
trials that provide evidence supporting
drug treatment of male infertility are not
available at present, the opportunity to
prove that these drugs are eff ective should
not be prevented, and rigorous examination
of drug therapy should be encouraged and
strengthened. Th erefore, I believe the above
conclusion in the EAU guidelines is poorly
conceived.

Full Text | PDF | 中文摘要 |